BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15259759)

  • 1. Fat-globule size in a propofol emulsion containing sodium metabisulfite.
    Driscoll DF; Dunbar JG; Marmarou A
    Am J Health Syst Pharm; 2004 Jun; 61(12):1276-80. PubMed ID: 15259759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical properties and stability of two emulsion formulations of propofol.
    Han J; Davis SS; Washington C
    Int J Pharm; 2001 Mar; 215(1-2):207-20. PubMed ID: 11250106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between Parenteral Lipid Emulsions and Container Surfaces.
    Gonyon T; Tomaso AE; Kotha P; Owen H; Patel D; Carter PW; Cronin J; Green JB
    PDA J Pharm Sci Technol; 2013; 67(3):247-54. PubMed ID: 23752751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free radical and drug oxidation products in an intensive care unit sedative: propofol with sulfite.
    Baker MT; Gregerson MS; Martin SM; Buettner GR
    Crit Care Med; 2003 Mar; 31(3):787-92. PubMed ID: 12626985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of lidocaine on the globule size distribution of propofol emulsions.
    Park JW; Park ES; Chi SC; Kil HY; Lee KH
    Anesth Analg; 2003 Sep; 97(3):769-771. PubMed ID: 12933399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Droplet-size distribution and stability of commercial injectable lipid emulsions containing fish oil.
    Gallegos C; Valencia C; Partal P; Franco JM; Maglio O; Abrahamsson M; Brito-de la Fuente E
    Am J Health Syst Pharm; 2012 Aug; 69(15):1332-5. PubMed ID: 22821793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Droplet-size distribution and stability of lipid injectable emulsions.
    Gallegos C; Partal P; Franco JM
    Am J Health Syst Pharm; 2009 Jan; 66(2):162-6. PubMed ID: 19139481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality by design approach for the preparation of fat-soluble vitamins lipid injectable emulsion.
    Deng Y; Zhong G; Wang Y; Wang N; Yu Q; Yu X
    Int J Pharm; 2019 Nov; 571():118717. PubMed ID: 31610279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yellowing of metabisulfite-containing propofol emulsion.
    Baker MT
    Am J Health Syst Pharm; 2001 Jun; 58(11):1042, 1044. PubMed ID: 11402481
    [No Abstract]   [Full Text] [Related]  

  • 10. Physicochemical stability of lipid injectable emulsions: correlating changes in large globule distributions with phase separation behavior.
    Gonyon T; Patel P; Owen H; Dunham AJ; Carter PW
    Int J Pharm; 2007 Oct; 343(1-2):208-19. PubMed ID: 17618071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of microorganisms in propofol and methohexital mixtures.
    Harvey BR; Ganzberg S
    J Oral Maxillofac Surg; 2003 Jul; 61(7):818-23. PubMed ID: 12856257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical Compatibility of Propofol-Sufentanil Mixtures.
    Zbytovská J; Gallusová J; Vidlářová L; Procházková K; Šimek J; Štěpánek F
    Anesth Analg; 2017 Mar; 124(3):776-781. PubMed ID: 27984227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PFAT5 and the Evolution of Lipid Admixture Stability.
    Klang MG
    JPEN J Parenter Enteral Nutr; 2015 Sep; 39(1 Suppl):67S-71S. PubMed ID: 26177666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of MCT/LCT-based total nutrient admixtures for neonatal use over 30 hours at room temperature: applying pharmacopeial standards.
    Driscoll DF; Silvestri AP; Bistrian BR
    JPEN J Parenter Enteral Nutr; 2010; 34(3):305-12. PubMed ID: 20467013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yellowing of metabisulfite-contaning propofol emulsion.
    Mirejovsky D
    Am J Health Syst Pharm; 2001 Jun; 58(11):1046-7. PubMed ID: 11402482
    [No Abstract]   [Full Text] [Related]  

  • 16. The pharmacopeial evolution of intralipid injectable emulsion in plastic containers: from a coarse to a fine dispersion.
    Driscoll DF
    Int J Pharm; 2009 Feb; 368(1-2):193-8. PubMed ID: 18996455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and Chemical Compatibility of Etomidate and Propofol Injectable Emulsions.
    Wang C; Wang S; Wu C; Lei L; Wang DX; Zhang Q
    Pharmacology; 2021; 106(11-12):644-657. PubMed ID: 34644710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PFAT5 stability assessment of Lipovenoes MCT in total nutrient admixtures.
    Gao S; Fan J; Jia X; Li B; Li X; Li Z; Li J
    Ann Palliat Med; 2021 Dec; 10(12):12244-12250. PubMed ID: 35016476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Globule-size distribution in injectable 20% lipid emulsions: Compliance with USP requirements.
    Driscoll DF
    Am J Health Syst Pharm; 2007 Oct; 64(19):2032-6. PubMed ID: 17893413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemical and physical stability of a 1:1 mixture of propofol and methohexital.
    Bennett J; Gross J; Nichols F; Chidambaram N; Burgess D
    Anesth Prog; 2001; 48(2):61-5. PubMed ID: 11515949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.